Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 2CNS 1

Conditions

Leukemia, Myeloid, Acute 191Anemia, Refractory, with Excess of Blasts 179Myelodysplastic Syndromes 175Leukemia 168Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Neoplasms 121Multiple Myeloma 116Venous Thromboembolism 111Anemia 108Leukemia, Myelomonocytic, Chronic 103Leukemia, Lymphocytic, Chronic, B-Cell 100Myeloproliferative Disorders 99Lymphoma, Non-Hodgkin 97Lymphoma 96Hodgkin Disease 85Thrombocytopenia 84Anemia, Aplastic 79Primary Myelofibrosis 67Lymphoma, Follicular 67Hematologic Neoplasms 63Leukemia, Myeloid, Chronic-Phase 61Lymphoma, Mantle-Cell 59Febrile Neutropenia 59Congenital Abnormalities 59Neoplasms, Plasma Cell 57Leukemia, Myeloid, Accelerated Phase 57Anemia, Refractory 57Leukemia, Myelogenous, Chronic, BCR-ABL Positive 56Blast Crisis 56Burkitt Lymphoma 53

Interventions

Rivaroxaban 1Registries 1Long-Term Synaptic Depression 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Dyskinesias × Classical hematology × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

NCT03886753 2020-07-30

Ilera

Children's Hospital of Philadelphia

Terminated
10 enrolled
Classical hematology

Autism Spectrum Disorder, Acquired Immunodeficiency Syndrome, Anemia, Sickle Cell, Epilepsy, Glaucoma, Huntington Disease, Multiple Sclerosis, Muscle Spasticity, Neoplasms, Pain, Intractable, Parkinson Disease, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Dyskinesias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡